(19)
(11) EP 3 377 083 A1

(12)

(43) Date of publication:
26.09.2018 Bulletin 2018/39

(21) Application number: 16820009.5

(22) Date of filing: 17.11.2016
(51) International Patent Classification (IPC): 
A61K 35/744(2015.01)
A61K 36/886(2006.01)
A23L 29/238(2016.01)
A61P 25/28(2006.01)
A61P 17/06(2006.01)
A61P 11/06(2006.01)
A61P 25/08(2006.01)
A61K 35/747(2015.01)
A23L 29/206(2016.01)
A23L 29/256(2016.01)
A61P 29/00(2006.01)
A61P 19/02(2006.01)
A61P 17/00(2006.01)
(86) International application number:
PCT/IB2016/056918
(87) International publication number:
WO 2017/085655 (26.05.2017 Gazette 2017/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 18.11.2015 IT UB20155700

(71) Applicant: Probiotical S.p.A.
28100 Novara (NO) (IT)

(72) Inventor:
  • MOGNA, Giovanni
    28100 Novara (IT)

(74) Representative: Hoffmann Eitle 
Hoffmann Eitle S.R.L. Piazza Sigmund Freud 1 Torre 2, Piano 22
20154 Milano
20154 Milano (IT)

   


(54) COMPOSITIONS WITH A SYNERGISTIC ACTION BETWEEN A MUCOADHERENT GELLING COMPLEX AGAINST THE PASSAGE OF ANTIGENS, AND IMMUNOMODULATORY ANTI-IL17 BACTERIA FOR USE IN THE TREATMENT OF UN¢ RELATED AUTOIMMUNE AND NEURODEGENERATIVE DISEASES.